trial

Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia

NCTId NCT05337904
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Active Not Recruiting
Enrollment 6 (estimated)
Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Primary completion 2026-03-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Active Not Recruiting
Enrollment
6 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2023-09-01
Primary completion
2026-03-01
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
On-StimulationOff-Stimulation

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauLead Sponsor

Investigators

1
Iluminada Corripio, MD, PhDPrincipal Investigator

Sites

1 total
Barcelona, Spain

Facts & assertions

4 sourced
Enrollment
6
Phase
NA
Primary Completion Date
2026-03-01
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
On-Stimulation
drug
Off-Stimulation
drug
lead_sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
company
indication
Deep Brain Stimulation
indication
Schizophrenia, Treatment-Resistant
indication
Schizophrenia
indication
investigator
Iluminada Corripio, MD, PhD
person